Sasco A J, Ah-Song R, Saez S, Kuttenn F
Programme d'épidémiologie pour la prévention du cancer, centre international de recherche sur le cancer, Lyon, France.
Bull Cancer. 1995 Jul;82 Suppl 3:186s-206s.
Tamoxifen, a synthetic antiestrogen widely used for the treatment of breast cancer, is also being proposed for the prevention of this cancer among women at high risk for the disease. Such an approach requires an objective and accurate evaluation, not only of the expected beneficial effects, but also of the potential iatrogenic side effects which could result from the administration of this drug to a population of healthy women. The present article summarizes our present knowledge which results from studies, all carried out on women with breast cancer: we review the side effects on the female genital apparatus, the ovarian and non ovarian endocrine side effects, the effects on cardio-vascular and thromboembolic risks, on bone metabolism and on ocular and hepatic side effects. The potential carcinogenic role is only briefly mentioned since it has already been the subject of a publication in this journal.
他莫昔芬是一种广泛用于治疗乳腺癌的合成抗雌激素药物,目前也被提议用于预防高危女性患乳腺癌。这种方法不仅需要对预期的有益效果进行客观准确的评估,还需要评估将这种药物应用于健康女性群体可能产生的潜在医源性副作用。本文总结了我们目前从针对乳腺癌女性开展的所有研究中获得的知识:我们回顾了其对女性生殖器官的副作用、卵巢和非卵巢内分泌副作用、对心血管和血栓栓塞风险的影响、对骨代谢的影响以及对眼部和肝脏的副作用。由于该杂志此前已发表过相关内容,因此仅简要提及了潜在的致癌作用。